Group 6F: Breast & Pan-Cancers; Antibody-drug Conjugates; Clinical Trials

Name: Group 6F: Breast & Pan-Cancers; Antibody-drug Conjugates; Clinical Trials
Start: 2023-06-15
End: 2023-06-15

Poster #1022: Sequential use of antibody-drug conjugate after antibody-drug conjugate for patients with metastatic breast cancer: ADC after ADC (A3) study

Poster #TPS3154: XMT-1660: A phase 1b trial of a B7-H4 targeted antibody drug conjugate (ADC) in breast, endometrial, and ovarian cancers